Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study

[1] Davis LE(1992)Early viral brain invasion in iatrogenic human immunodeficiency virus infection Neurology 42 1736-1739

[2] Hjelle BL(2001)HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health AIDS 15 837-845

[3] Miller VE(1997)Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group Ann Neurol 42 679-688

[4] Palmer DL(1997)Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain Ann Neurol 42 689-698

[5] Llewellyn AL(2005)Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment BMC Infect Dis 5 98-1696

[6] Merlin TL(2006)Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure J Infect Dis 194 1686-276

[7] Young SA(1999)Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection J Acquir Immune Defic Syndr 21 271-2149

[8] Mills RG(2002)Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection AIDS 16 2145-300

[9] Wachsman W(2007)Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex Handb Clin Neurol 85 261-552

[10] Wiley CA(2008)Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection J Acquir Immune Defic Syndr 47 544-524

[1] Davis LE(1992)Early viral brain invasion in iatrogenic human immunodeficiency virus infection Neurology 42 1736-1739

[2] Hjelle BL(2001)HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health AIDS 15 837-845

[3] Miller VE(1997)Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group Ann Neurol 42 679-688

[4] Palmer DL(1997)Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain Ann Neurol 42 689-698

[5] Llewellyn AL(2005)Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment BMC Infect Dis 5 98-1696

[6] Merlin TL(2006)Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure J Infect Dis 194 1686-276

[7] Young SA(1999)Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection J Acquir Immune Defic Syndr 21 271-2149

[8] Mills RG(2002)Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection AIDS 16 2145-300

[9] Wachsman W(2007)Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex Handb Clin Neurol 85 261-552

[10] Wiley CA(2008)Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection J Acquir Immune Defic Syndr 47 544-524